Table 5 Average survival following pleurodesis according to primary malignancy.
PATIENTS | |
|---|---|
MALIGNANCY | Average survival (months) |
Breast cancer | 13.6 |
Ovarian cancer | 13.1 |
Lymphoma | 10.2 |
Pleural mesothelioma | 9.6 |
Colon cancer | 8.4 |
Melanoma | 7.8 |
Parotid gland cancer | 7.0 |
Non small cell lung cancer | 6.7 |
Small cell lung cancer | 6.6 |
Uterine cancer | 6.4 |
Sarcoma | 6.4 |
Testicular cancer | 6.0 |
Gastric cancer | 4.9 |
Oesophageal cancer | 4.0 |
Hepatocellular cancer | 3.4 |
Gallbladder cancer | 3.0 |